Elderly: Clinical Trials

13 trials for Elderly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown, 1 recruiting, 1 terminated. 13 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 8, Unknown 3, Recruiting 1, Terminated 1
Phase 25Unknown 3, Completed 1, Recruiting 1

Follow Elderly: new trials by email Literature Review of Elderly trials Research Report on Elderly

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment
Metfomin - Mild Cognitive Impairment, Overweight or Obesity
Phase 1 / Phase 2RecruitingFudan University542025-09-012026-02-09
NK Cell Therapy Recurrent/Refractory Elderly AML
Allogeneic NK cell regimen group - AML, Recurrent
Phase 1 / Phase 2UnknownThe Second Hospital of Shandong University102020-12-012020-10-22
This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects
GLPG1205 50mg q.d., Placebo oral capsule, GLPG1205 250 loading dose and 50mg q.d. maintenance dose - Healthy, Elderly
Phase 1CompletedLakefront Biotherapeutics NV322016-10-182017-04-05
TNS for Treating Major Depressive Disorder in the Elderly
Transcutaneous Trigeminal Nerve Stimulation - Major Depressive Disorder, Elderly
Phase 1 / Phase 2UnknownSanta Casa Medical School102015-10-012015-09-29
A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly
Rosuvastatin - Elderly
Phase 1CompletedSeoul National University Hospital202015-04-012018-10-22
Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine
Lactobacillus rhamnosus GG ATCC 53103 (LGG), Placebo - Healthy, Elderly
Phase 1CompletedMassachusetts General Hospital282011-09-012017-01-11
Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
Lactobacillus Rhamnosus GG, ATCC 53103 (LGG) - Healthy, Elderly
Phase 1CompletedMassachusetts General Hospital152010-12-012017-01-11
Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects
AZD9742, Placebo - Tolerability, Healthy
Phase 1CompletedAstraZeneca122010-06-012010-08-03
The Role of Mind Body Therapy in Geriatric Rehabilitation
mind-body intervention - Elderly, Treatment
Phase 1 / Phase 2UnknownTel-Aviv Sourasky Medical Center2010-01-012010-02-05
A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.
PF-04447943 - Healthy, Elderly
Phase 1CompletedPfizer322009-01-012009-06-12
A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers
PF-04447943, Placebo - Healthy, Elderly
Phase 1TerminatedPfizer102008-08-012009-02-25
Yoga Program in Respiratory Function
yoga practice - Elderly
Phase 1 / Phase 2CompletedCatholic University of Brasília362007-03-012008-10-08
Paracetamol and Glutathion
Paracetamol - Chronic Pain, Elderly
Phase 1CompletedUniversity Hospital, Clermont-Ferrand182007-02-012010-05-05

Narrower conditions

Chronic Pain (1)  ·  Cognitive Dysfunction (1)  ·  Depressive Disorder, Major (1)  ·  Influenza, Human (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Recurrence (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Mental Disorders (2)  ·  Signs and Symptoms (2)  ·  Body Weight (1)  ·  Cognition Disorders (1)  ·  Depressive Disorder (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Mood Disorders (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Orthomyxoviridae Infections (1)  ·  Overnutrition (1)

Interventions

6-(4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one (2)  ·  Acetaminophen (1)  ·  GLPG1205 (1)  ·  Rosuvastatin Calcium (1)

Sponsors

Massachusetts General Hospital (2)  ·  Pfizer (2)  ·  AstraZeneca (1)  ·  Catholic University of Brasília (1)  ·  Fudan University (1)  ·  Lakefront Biotherapeutics NV (1)  ·  Santa Casa Medical School (1)  ·  Seoul National University Hospital (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  The Second Hospital of Shandong University (1)  ·  University Hospital, Clermont-Ferrand (1)

Countries

United States (5)  ·  China (2)  ·  Belgium (1)  ·  Brazil (1)  ·  France (1)

Top investigators

Billings W Billings, MD (1)  ·  Brendan Smyth (1)  ·  Chengyun Zheng, Ph.D. (1)  ·  Colleen Jensen (1)  ·  Helen Timis, MBChB MICR (1)  ·  Jae-Yong Chung (1)  ·  Lidia MA Bezerra, Ms. (1)  ·  Patricia L Hibberd, MD, PhD (1)  ·  Patricia L. Hibberd, MD, PhD (1)  ·  Xiaoming Tao (1)

Results publications

PMID 25054988, PMID 25150403, PMID 25438151, PMID 26859761